Journal of the American Society of Echocardiography
Volume 33, Issue 9, September 2020, Pages 1116-1122
Clinical InvestigationIdentifying Cardiovascular Risk in Systemic Lupus ErythematosusLeft Ventricular Systolic Function in Patients with Systemic Lupus Erythematosus and Its Association with Cardiovascular Events
Identifying Cardiovascular Risk in Systemic Lupus Erythematosus
Under a Creative Commons license
open access
Keywords
Left ventricular function
global longitudinal strain
systemic lupus erythematosus
cardiovascular outcome
Abbreviations
CAD
Coronary artery disease
CVA
Cerebrovascular accident
GLS
Global longitudinal strain
HR
Hazard ratio
LV
Left ventricular
LVEF
Left ventricular ejection fraction
SLE
Systemic lupus erythematosus
SLEDAI
Systemic lupus erythematosus disease activity index
STE
Speckle-tracking echocardiography
Cited by (0)
Dr. Gegenava has received funding from the European Society of Cardiology in the form of a European Society of Cardiology research grant (application number R-2017-028).
The Department of Cardiology at Leiden University Medical Center has received unrestricted research grants from Biotronik, Medtronic, Boston Scientific, GE Healthcare, and Edwards Lifesciences. Dr. Ajmone-Marsan has received speaking fees from Abbott Vascular.
Drs. T. Gegenava and M. Gegenava contributed equally to this work.
Roberto M. Lang, MD, FASE, served as guest editor for this report.
Conflicts of Interest: None.
2020 by the American Society of Echocardiography. Published by Elsevier Inc.